Literature DB >> 9374365

Biliary dyskinesia: role of the sphincter of Oddi, gallbladder and cholecystokinin.

S Krishnamurthy1, G T Krishnamurthy.   

Abstract

The availability of objective and quantitative diagnostic tests in recent years has allowed more precise documentation of biliary dyskinesia. Biliary dyskinesia consists of two disease entities situated at two different anatomical locations: sphincter of Oddi spasm, at the distal end of the common duct, and cystic duct syndrome, in the gallbladder. Both conditions are characterized by a paradoxical response in which the sphincter of Oddi and the cystic duct contract (and impede bile flow) instead of undergoing the normal dilatation, when the physiological dose of cholecystokinin is infused. Quantitative cholescintigraphy can clearly differentiate one disease entity from the other. The therapies of choice are sphincterotomy, sphincteroplasty or antispasmodics for sphincter of Oddi spasm and cholecystectomy for cystic duct syndrome. After quantitative cholescintigraphy, the final impression should identify the disease entity by name to assist the referring physician in making an appropriate therapeutic decision; a mere statement that a test is consistent with biliary dyskinesia is no longer sufficient.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9374365

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  11 in total

1.  The role of sphincteroplasty in adverse effect of anomalous pancreaticobiliary duct union in an animal model.

Authors:  Seok Joo Han; Airi Han; Myung-Joon Kim; Hogun Kim
Journal:  Pediatr Surg Int       Date:  2006-09-20       Impact factor: 1.827

2.  Pain provocation and low gallbladder ejection fraction with CCK cholescintigraphy are not predictive of chronic acalculous gallbladder disease symptom relief after cholecystectomy.

Authors:  Michael A Edwards; Benjamin Mullenbach; Sherman M Chamberlain
Journal:  Dig Dis Sci       Date:  2014-05-23       Impact factor: 3.199

Review 3.  Exercising the hepatobiliary-gut axis. The impact of physical activity performance.

Authors:  Emilio Molina-Molina; Raquel Lunardi Baccetto; David Q-H Wang; Ornella de Bari; Marcin Krawczyk; Piero Portincasa
Journal:  Eur J Clin Invest       Date:  2018-06-14       Impact factor: 4.686

Review 4.  Impaired intestinal cholecystokinin secretion, a fascinating but overlooked link between coeliac disease and cholesterol gallstone disease.

Authors:  Helen H Wang; Min Liu; Xiaodan Li; Piero Portincasa; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2017-03-08       Impact factor: 4.686

5.  Proton pump inhibitors reduce gallbladder function.

Authors:  M A Cahan; L Balduf; K Colton; B Palacioz; W McCartney; T M Farrell
Journal:  Surg Endosc       Date:  2006-07-20       Impact factor: 4.584

Review 6.  Biliary dyskinesia in pediatrics.

Authors:  Grzegorz Telega
Journal:  Curr Gastroenterol Rep       Date:  2006-04

7.  Biliary dyskinesia: is the problem with Oddi?

Authors:  J Wood; A J A Holland; A Shun; H C O Martin
Journal:  Pediatr Surg Int       Date:  2004-02-10       Impact factor: 1.827

8.  Lack of endogenous cholecystokinin promotes cholelithogenesis in mice.

Authors:  H H Wang; M Liu; P Portincasa; P Tso; D Q-H Wang
Journal:  Neurogastroenterol Motil       Date:  2015-11-25       Impact factor: 3.598

9.  Associations between serum leptin levels, hyperlipidemia, and cholelithiasis in dogs.

Authors:  Sungin Lee; Oh-Kyeong Kweon; Wan Hee Kim
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

10.  Role of laparoscopic cholecystectomy in the management of chronic right upper quadrant pain due to biliary dyskinesia: a systematic review and meta-analysis.

Authors:  Saad Rehman; Krishna Kumar Singh; Muhammad Shafique Sajid
Journal:  Transl Gastroenterol Hepatol       Date:  2019-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.